Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 26;11(2):e038399.
doi: 10.1136/bmjopen-2020-038399.

Prospective, randomised, controlled study on the efficacy and safety of different strategies of tranexamic acid with total blood loss, blood transfusion rate and thrombogenic biomarkers in total knee arthroplasty: study protocol

Yong Yang  1   2 , Zheng Wang  1   2 , Faxuan Wang  3 , Xin Zhao  1 , Kaijie Yang  1 , Jinlong He  1 , Yun Jin  1 , Haibo Yang  1 , Dong Ding  2 , Qunhua Jin  4
Affiliations

Prospective, randomised, controlled study on the efficacy and safety of different strategies of tranexamic acid with total blood loss, blood transfusion rate and thrombogenic biomarkers in total knee arthroplasty: study protocol

Yong Yang et al. BMJ Open. .

Abstract

Introduction: Total knee arthroplasty (TKA) is a common and highly effective orthopaedic procedure for treating end-stage knee osteoarthritis. Tranexamic acid (TXA) has become a routine part of perioperative care in TKAs. The best practices regarding the delivery method of TXA in TKA remain controversial. Plasminogen activator inhibitor-1 (PAI-1), thrombin-antithrombin (TAT) complexes and prothrombin fragment F1+2 (F1+2) have been demonstrated to be elevated in patients with venous thromboembolism (VTE). The aim of this trial was to investigate the most efficacious delivery method of TXA (comparison of intravenous and topical applications and comparison of three topical applications) and to evaluate the safety of TXA strategies by investigating the effect of TXA on the plasma D-dimer, PAI-1, TAT and F1+2 levels.

Methods and design: This trial is a prospective, randomised, controlled study that will evaluate the efficacy and safety of strategies of TXA. A total of 250 patients undergoing primary TKA will be randomly allocated to five groups for different TXA applications. The primary outcome is total blood loss. The secondary outcomes are blood transfusion rate, drainage volume, plasma D-dimer, PAI-1, TAT and F1+2 levels, maximum haemoglobin drop, wound complications, VTE and length of hospital stay.

Ethics and dissemination: This study's protocol is in accordance with the declaration of Helsinki. The ethics committee of the General Hospital of Ningxia Medical University approved this study (approval ID: 2020-505). The results of this study will be disseminated in international peer reviewed journals.

Trial registration number: ChiCTR2000030624.

Keywords: blood bank & transfusion medicine; knee; surgery.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
CONSORT flow diagram. DI, drainage injection; PI, periarticular tissue injection; TI, topical irrigation.
See this image and copyright information in PMC

References

    1. Kurtz S, Ong K, Lau E, et al. . Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007;89:780–5. 10.2106/00004623-200704000-00012 - DOI - PubMed
    1. Xie J, Hu Q, Huang Z, et al. . Comparison of three routes of administration of tranexamic acid in primary unilateral total knee arthroplasty: analysis of a national database. Thromb Res 2019;173:96–101. 10.1016/j.thromres.2018.11.025 - DOI - PubMed
    1. Hart A, Khalil JA, Carli A, et al. . Blood transfusion in primary total hip and knee arthroplasty. incidence, risk factors, and thirty-day complication rates. J Bone Joint Surg Am 2014;96:1945–51. 10.2106/JBJS.N.00077 - DOI - PubMed
    1. Harvey AR, Basavaraju SV, Chung K-W, et al. . Transfusion-related adverse reactions reported to the National healthcare safety network Hemovigilance module, United States, 2010 to 2012. Transfusion 2015;55:709–18. 10.1111/trf.12918 - DOI - PMC - PubMed
    1. Kozanek M, Menendez ME, Ring D. Association of perioperative blood transfusion and adverse events after operative treatment of proximal humerus fractures. Injury 2015;46:270–4. 10.1016/j.injury.2014.11.032 - DOI - PubMed

Publication types